This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Hypertension and antidepressants

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • hypertension is an uncommon side effect of antidepressant treatment; hypertension occurs in less than 1% of cases and severity ranges from mild to life-threatening; also antidepressant treatment can exacerbate hypertension in those with existing disease

  • there should be routine measurement of blood pressure before, and occasionally during, a treatment course with antidepressants; this should even be undertaken in patients with no prior history of hyper- or hypo- tension (1)

  • selective serotonin reuptake inhibitors and tricyclic antidepressants; hypertension occurs very rarely with these drugs (less than 0.01% of cases) and is generally clinically insignificant

  • roboxetine - the incidence of hypertension in clinical trials is 3%; not clinically significant from placebo but may be important if a patient has pre-existing hypertension

  • monoamine oxidase inhibitors and venlafaxine are described in the menu items

Reference:

  • 1) Prescribers' Journal 2000; 40 (2): 169-174.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.